L. Bara

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

François Cambien, Odette Poirier, Laure Lecerf et al. · Nature · 1992 · 1.9K citations

Medicine, Genetics, Molecular Genetics +14

β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction

Isabelle Behague, Odette Poirier, Viviane Nicaud et al. · Circulation · 1996 · 290 citations

Life Sciences, Cardiology, Genetics +16

The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

Shu Ye, FR Green, P.Y. Scarabin et al. · Thrombosis and Haemostasis · 1995 · 236 citations

Life Sciences, Genetics, Molecular Genetics +13

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

L. Bara, Eliane M. Billaud, G. Gramond et al. · Thrombosis Research · 1985 · 193 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg

Armand Frydman, L. Bara, Y. He Roux et al. · The Journal of Clinical Pharmacology · 1988 · 168 citations

Medicine, Pharmacokinetics, Pharmacology +11